Marshall Wace’s Sana Biotechnology SANA Stock Holding History

Marshall Wace’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Buy	2,931,436 +2,266,979	+341%	+$7.3M	0.01%	1028
2026 Q1	$1.91M	Buy	664,457 +575,669	+648%	+$2.27M	﹤0.01%	1810
2025 Q4	$361K	Buy	+88,788	New	+$398K	﹤0.01%	2382
2025 Q2	–	Sell	-211,227	Closed	-$355K	–	3104
2025 Q1	$355K	Buy	211,227 +189,905	+891%	+$531K	﹤0.01%	2202
2024 Q4	$34.8K	Sell	21,322 -372,359	-95%	-$1.11M	﹤0.01%	2501
2024 Q3	$1.64M	Buy	393,681 +205,968	+110%	+$1.08M	﹤0.01%	1442
2024 Q2	$1.02M	Sell	187,713 -682,272	-78%	-$5.44M	﹤0.01%	1676
2024 Q1	$8.7M	Buy	+869,985	New	+$6.52M	0.01%	792
2023 Q4	–	Sell	-79,069	Closed	-$306K	–	2560
2023 Q3	$306K	Sell	79,069 -8,560	-10%	-$46K	﹤0.01%	1878
2023 Q2	$522K	Buy	+87,629	New	+$505K	﹤0.01%	1963
2022 Q4	–	Sell	-29,180	Closed	-$175K	–	3356
2022 Q3	$175K	Buy	+29,180	New	+$211K	﹤0.01%	3113

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Marshall Wace's SANA Position: Q2 2026 in Review

Marshall Wace increased its Sana Biotechnology (SANA) stake by 341% in Q2 2026, buying an estimated $7.3M and bringing the position to 2,931,436 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #1028.

Marshall Wace first reported a position in SANA in Q3 2022 and has held it in 11 quarters since. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Marshall Wace held 2,931,436 shares of Sana Biotechnology worth $10.2M as of Q2 2026.
Marshall Wace bought 2,266,979 Sana Biotechnology shares in Q2 2026, an estimated $7.3M.
Sana Biotechnology made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1028 holding.
Marshall Wace first reported a position in Sana Biotechnology in Q3 2022 and has held it in 11 quarters since.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.